Get in Touch
0
0

Insights Blog

Explore our thought leadership insights, as life science technologies evolve and accelerate.
Filters
Reset All
Search
Industries
Insight Type
Topics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blog Article
Financial Services
NVIDIA’s $20B xAI Deal: Lessons for Life Science Tools & Diagnostics Leaders
How NVIDIA’s $20B xAI deal is redefining innovation financing — and what life science tools & diagnostics leaders can learn from its SPV model.
October 10, 2025
Blog Article
Financial Services
NVIDIA’s $20B xAI Deal: Lessons for Life Science Tools & Diagnostics Leaders
How NVIDIA’s $20B xAI deal is redefining innovation financing — and what life science tools & diagnostics leaders can learn from its SPV model.
October 10, 2025
Diagnostics Market
life science research tools
Research Tools
DeciBio Ventures
AI / Machine Learning
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | September Round-Up 2025
Liquid Biopsy (LBx) continued to develop through September, featuring new regulatory approvals and partnerships as well as trial launches and study results.
October 9, 2025
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | September Round-Up 2025
Liquid Biopsy (LBx) continued to develop through September, featuring new regulatory approvals and partnerships as well as trial launches and study results.
October 9, 2025
Liquid Biopsy
DeciBio News
Pharma & Biotech
Precision Medicine in Europe: Policy and Approvals | Q3 2025 Update
Explore the latest policy shifts and approvals shaping the future of precision medicine across Europe in our Q3 2025 round-up.
October 6, 2025
DeciBio News
Pharma & Biotech
Precision Medicine in Europe: Policy and Approvals | Q3 2025 Update
Explore the latest policy shifts and approvals shaping the future of precision medicine across Europe in our Q3 2025 round-up.
October 6, 2025
Clinical Diagnostics
Companion Diagnostics
Precision Medicine
Proteomics Market
life science research tools
Blog Article
Financial Services
Re-evaluating How We Build Life Science Companies for the Next Growth Phase
A candid conversation between DeciBio and The Biotech Builder on why the life sciences industry must innovate not just in science, but in how it finances, hires, and structures companies to build a more resilient future.
October 6, 2025
Blog Article
Financial Services
Re-evaluating How We Build Life Science Companies for the Next Growth Phase
A candid conversation between DeciBio and The Biotech Builder on why the life sciences industry must innovate not just in science, but in how it finances, hires, and structures companies to build a more resilient future.
October 6, 2025
NGS
Diagnostics Market
life science research tools
Research Tools
DeciBio Ventures
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | September Round-Up 2025
Read about the latest updates in the Next-Generation Therapeutics space in the month of September.
October 1, 2025
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics | September Round-Up 2025
Read about the latest updates in the Next-Generation Therapeutics space in the month of September.
October 1, 2025
Next-Generation Therapeutics
Blog Article
Financial Services
Discussion with Svetlana Valonis: Navigating Life Sciences Strategy and M&A in 2025
AI, capital discipline, and smart M&A are reshaping biopharma strategy—DeciBio’s Stephane Budel and advisor Svetlana Valonis break down what’s next.
September 29, 2025
Blog Article
Financial Services
Discussion with Svetlana Valonis: Navigating Life Sciences Strategy and M&A in 2025
AI, capital discipline, and smart M&A are reshaping biopharma strategy—DeciBio’s Stephane Budel and advisor Svetlana Valonis break down what’s next.
September 29, 2025
NGS
Diagnostics Market
life science research tools
Research Tools
DeciBio Ventures
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch
© DeciBio 2023 | All rights reserved
Privacy
Terms & Conditions